Evidence map›Paper›PMID 19519436›Full record

ReviewCurrent pharmaceutical design2009

Lactoferrin as a natural immune modulator.

Jeffrey K Actor, Shen-An Hwang, Marian L Kruzel

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Current pharmaceutical design, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04335058 (Lactoferrin With Iron Versus Iron Alone in Treatment of Anemia In Chronic Liver Disease), which is not on this map. Cited by 194 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
194citing papers in PubMed, 3 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04335058 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Lactoferrin With Iron Versus Iron Alone in Treatment of Anemia In Chronic Liver Disease

TypeinterventionalSponsorPost Graduate Institute of Medical Education and Research, ChandigarhRan2020 to 2023Enrolled130ConditionsIron Deficiency Anemia, Chronic Liver FailureArmsLactoferrin + Iron Supplement, Iron Supplement
3 · Its place in the literature

Who cites it

194 citing papers in PubMed, 3 syntheses or guidelines pooled it, 442 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. ExploitingFrontiers in immunology · 2026
    Article

134 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeffrey K ActorDepartment of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston, TX 77030, USA. Jeffrey.K.Actor@uth.tmc.edu
Shen-An Hwang
Marian L Kruzel
The University of Texas Health Science Center at Houston · US

Funding

Lactoferrin as an Adjuvant for Cellular ImmunityR42AI051050 · NIAID · PHARMAREVIEW CORPORATION · PI ACTOR, JEFFREY K · 2005 to 2010
$4.1M
Lactoferrin for Immunomodulation of Systemic Inflammatory Response SyndromeR41GM079810 · NIGMS · PHARMAREVIEW CORPORATION · PI ACTOR, JEFFREY K · 2007 to 2008
$298k
NIAID NIH HHS R42 AI051050NIAID NIH HHS R42AI051050-02NIGMS NIH HHS 1R41GM-079810-01NIGMS NIH HHS R41 GM079810
6 · The paper itself

Abstract

Lactoferrin, an iron-binding glycoprotein, is a cell-secreted mediator that bridges innate and adaptive immune function in mammals. It is a pleiotropic molecule that directly assists in the influence of presenting cells for the development of T-helper cell polarization. The aim of this review is to provide an overview of research regarding the role of lactoferrin in maintaining immune homeostasis, in particular as a mediator of immune responses to infectious assault, trauma and injury. These findings are critically relevant in the development of both prophylactic and therapeutic interventions in humans. Understanding these particular effects of lactoferrin will provide a logical framework for determining its role in health and disease.

Indexed as

AnimalsHumansImmunity, CellularImmunity, InnateImmunologic FactorsLactoferrinOxidative StressReceptors, Cell SurfaceStaphylococcal InfectionsSystemic Inflammatory Response SyndromeImmunologic FactorsLactoferrinlactoferrin receptorsReceptors, Cell Surface

Identifiers

PMID19519436
PMCPMC2915836
OpenAlexW2150336290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.